GeneralConnection.com
➔
Dictionary
Dictionary Search
Go Find!
mutate
Synonyms
Verb
1. change
Usage
Adagrasib Plus Cetuximab Falls Short in KRAS G12C–Mutated Colorectal Cancer - Targeted Oncology
TOP Trial: Chemo-Osimertinib in TP53-Mutant EGFR-Mutated NSCLC - CancerNetwork
TP53 Status and Time Toxicity Shape Sequencing Decisions in EGFR-Mutated NSCLC - OncLive
DEVO’s Duty Now for the Future: Mutate, Don’t Stagnate (Part 2 of 4) - Musoscribe
How fast does human DNA mutate? Scientists finally know - AOL.com
In ‘Mutate,’ a Leukemia Survivor Redefines Her Relationship With Dance - L.A. Dance Chronicle
Mutating mice becoming growing problem in Philadelphia, Rutgers researchers say - 6abc Philadelphia
Heroin’s “Mutate or Die” Premiere Photos - Thrasher Magazine
Mutating mice becoming growing problem in New York City, Rutgers researchers say - ABC7 New York
“Still a Ways to Go”: Takeaways From ASCO 2026 in EGFR-Mutated NSCLC - Oncology News Central
Deutsche Bank: The dollar isn't dying, it's mutating into a risk asset - investingLive
Devo Perform in the Hudson Valley this Summer in their “Mutate, Don’t Stagnate” Tour - Chronogram Magazine
Why Do Viruses Like COVID-19 and the Flu Mutate Rapidly and What Does it Mean for Vaccines? - Discover Magazine
Clinical Scenario: CNS-Only Progression on Osimertinib in EGFR-Mutated NSCLC - OncLive
DEVO’s Duty Now for the Future: Mutate, Don’t Stagnate (Part 4 of 4) - Musoscribe
Ziftomenib Expands Role in Relapsed/Refractory NPM1-Mutated AML - Targeted Oncology
First-Line/Maintenance Ibrutinib Improves Survival in TP53-Mutated MCL - CancerNetwork
DEVO’s Duty Now for the Future: Mutate, Don’t Stagnate (Part 1 of 4) - Musoscribe
Examining the Implications of the VIKTORIA-1 Study 2 Data in PIK3CA-Mutated Breast Cancer - OncLive
DEVO’s Duty Now for the Future: Mutate, Don’t Stagnate (Part 3 of 4) - Musoscribe
Frontline Treatment Selection in EGFR-Mutated Non-Small Cell Lung Cancer: Monotherapy Versus Combination Strategies - OncLive
What Do ASCO 2026 Data Mean for ESR1-Mutated Breast Cancer Care? - Oncology News Central
Zongertinib, Sevabertinib Reshape Treatment Landscape for Patients With HER2-Mutated NSCLC - OncLive
Mutating rats, mice becoming resistant to poison, research suggests - NewsNation
Adagrasib plus cetuximab fails to outperform chemotherapy in KRAS G12C-mutated metastatic colorectal cancer - ESMO Daily Reporter
VS-7375 Exhibits Activity in KRAS G12D–Mutated Solid Tumors - CancerNetwork
Heroin's "Mutate or Die" Video - Thrasher Magazine
Hantavirus has not mutated to be more transmissible: WHO - The Hill
Introduction and Frontline Treatment Options for EGFR-Mutated NSCLC - OncLive
Oral SERDs in ESR1-Mutated Disease: Clinical Differentiation and Use - Docwire News
Your DNA is changing all the time. Here’s why : Short Wave - NPR
The Stewards of Chernobyl Are Passing Mutations Down to Their Children - Popular Mechanics
Integrated Molecular Analysis Identifies Determinants of Outcomes in TP53 -Mutated DLBCL - The ASCO Post
DEVO: Mutate Don’t Stagnate 6/12 at Borgata - 95.7 BEN FM
Gilteritinib Yields Comparable Efficacy vs Midostaurin in Newly Diagnosed FLT3-Mutated AML but Fails to Meet Phase 3 Primary End Point - OncLive
We Are All Constantly Mutating—and That’s a Good Thing - The New Yorker
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer - The New England Journal of Medicine
Amivantamab Plus Lazertinib Improves Survival in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer - HMP Global Learning Network
Camizestrant Extends PFS and PFS2 in ESR1-Mutated Advanced Breast Cancer - CancerNetwork
Tanning beds mutate skin cells far beyond the reach of ordinary sunlight, study shows - Medical Xpress
Catching Cancer’s Earliest Moments: How Mutated Cells Transform Their Local Environment So a Tumor Can Develop - Memorial Sloan Kettering Cancer Center
Optimizing Targeted Therapy in Early-Stage EGFR-Mutated NSCLC - CancerNetwork
Microbes mutated in space hint at biomedical benefits to humans on Earth - UW–Madison News
Head MTG designer explains why the Teenage Mutant Ninja Turtles don't mutate - wargamer.com
Study shows your genes determine how fast your DNA mutates with age - UCLA Health
Malware Now Uses AI During Execution to Mutate and Collect Data, Google Warns - SecurityWeek
DEVO announce 2026 Mutate Don't Stagnate Tour - BrooklynVegan
Navigating the Challenging Landscape of TP53-Mutated MDS and MPN - Targeted Oncology
Devo to wrap up their Mutate, Don’t Stagnate U.S. tour with August Orlando concert - Orlando Weekly
Daraxonrasib for Previously Treated RAS -Mutated Pancreatic Cancer - The ASCO Post
FDA Approves Vepdegestrant for ESR1-Mutated ER+/HER2− Advanced Breast Cancer - Targeted Oncology
First-Line Onvansertib + Standard of Care Improves Antitumor Activity in RAS-Mutated mCRC - ASCO Daily News
FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer - OncLive
DEVO Announces “Mutate, Don’t Stagnate” 2026 Tour - Pollstar News
DEVO: Mutate Don’t Stagnate - KRXI
Joel W. Neal, MD, PhD, on the CHRYSALIS-2 Study in Atypical EGFR-Mutated Advanced NSCLC - The ASCO Post
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms - Leukemia - Nature
FDA Approves Vepdegestrant for ESR1-Mutated, ER-Positive, HER2-Negative Advanced Breast Cancer - AJMC
EGFR-Mutated NSCLC: Integrating Emerging ELCC Data Into Treatment Sequencing - OncLive
Nuclear transcriptional condensates as drivers and therapeutic targets in NPM1-mutated AML - ScienceDirect.com
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors - The New England Journal of Medicine
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial - The Lancet
Plixorafenib Receives FDA BTD for BRAF V600E–Mutated High-Grade Glioma - CancerNetwork
I’m Deeply Upset Subnautica 2 Won’t Let Me Mutate Into A Little Aquatic Freak - GameSpot
CHMP Recommends Camizestrant Plus CDK4/6 Inhibitor for ESR1-Mutated HR+ Advanced Breast Cancer - OncLive
New FDA-Approved Targeted Therapy for ESR1-Mutated Metastatic Breast Cancer - news.cancerconnect.com
Future Directions and Unmet Needs in EGFR Mutated Metastatic Non-Small Cell Lung Cancer - CancerNetwork
FDA Approves Vepdegestrant for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer - Oncology Nursing News
KRYSTAL-10 at ESMO GI 2026: Adagrasib Plus Cetuximab vs Chemotherapy in KRAS G12C-Mutated mCRC - Oncodaily
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC - Targeted Oncology
The 11 Best Mutate Commanders in Magic Ranked - Draftsim
Devo Extends 2026 Mutate, Don't Stagnate Tour - See All the Dates - Ultimate Classic Rock
Selecting Combination Versus Monotherapy in EGFR Mutated Metastatic Non-Small Cell Lung Cancer - CancerNetwork
Talazoparib Plus Enzalutamide Hits Primary End Point in HRR Gene–Mutated mCSPC - OncLive
Ziftomenib Plus 7+3 Yields Strong Responses in NPM1-Mutated, KMT2A-Rearranged AML: Eunice S. Wang, MD - AJMC
EGFR-Mutated NSCLC: Mechanism and Clinical Role of TROP2-Directed ADCs - OncLive
Scientists say rat virus is mutating – but no critical changes yet - The Telegraph
Sub-Q Amivantamab Offers Greater Convenience for Patients With EGFR-Mutated NSCLC: Estelamari Rodriguez, MD, MPH - AJMC
Frontline Sevabertinib Earns FDA Priority Review in HER2-Mutated NSCLC - CancerNetwork
Cardiff Onvansertib Shows 72% Response Rate in RAS-Mutated Colorectal Cancer - The Clinical Trial Vanguard
EGFR-Mutated NSCLC: Emerging Role of TROP2-Directed Antibody–Drug Conjugates - OncLive
Onvansertib Triplet Improves Efficacy in First-Line RAS-Mutated mCRC - CancerNetwork
FDA Approves Encorafenib for Metastatic BRAF V600E–Mutated Colorectal Cancer - The ASCO Post
Evolving Adjuvant Therapy in Early-Stage EGFR-Mutated NSCLC: Insights From ADAURA - CancerNetwork
Devo extends Mutate, Don’t Stagnate tour through June - Everett Post
Amivantamab Plus Lazertinib Produces Clinically Meaningful OS in Atypical EGFR-Mutated Advanced NSCLC - OncLive
Unpacking the Advantages and Limitations of Leading Frontline Regimens in EGFR-Mutated NSCLC - OncLive
Less Is More: Advancing Care in TP53-Mutated Myeloid Malignancies - OncLive
AI-designed Vaccine Protects Against Viruses as they Mutate - Labcompare
Evolving Frontline Treatment Options in EGFR-Mutated NSCLC - OncLive
Navigating Treatment Decisions for EGFR-Mutated NSCLC With High-Risk Features - OncLive
Rezatapopt Generates Rapid, Durable Responses Across Subgroups in Pretreated TP53 Y220C–Mutated Ovarian Cancer - OncLive
Factors Driving Frontline Treatment Selection in EGFR-Mutated NSCLC - OncLive
Post-HSCT Gilteritinib May Improve Outcomes in R/R FLT3-Mutated AML - Targeted Oncology
FDA Accepts NDA for Giredestrant/Everolimus in ESR1-Mutated Breast Cancer - CancerNetwork
Niraparib and Abiraterone Acetate Nets European Approval in BRCA1/2-Mutated mHSPC - OncLive
FDA Approves Regimen for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer - The ASCO Post
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia – a HARMONY study - Nature
Screening of kinase inhibitors in the triple negative KRAS G13D-mutated MDA-MB-231 breast cancer cell line - Nature
Subcutaneous Administration in EGFR Mutated Metastatic Non-Small Cell Lung Cancer - CancerNetwork
Foreign Language Equivalents
Foreign Language Equivalents of 'mutate'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
mitate, mutaate, mutatee, mutaye, muttate, ,utate, mutat, muyate, mutatr, nutate, mmutate, mutare, muate, mutste, mutae, muatte, mutte, mytate, utate, mtuate, muutate, mtate, mutatw, murate, mutatte, muttae, umtate, mutaet
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z